Sansure Biotech (SHSE:688289) Long-Term Debt : ¥810 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Long-Term Debt?

Sansure Biotech's Long-Term Debt for the quarter that ended in Mar. 2025 was ¥810 Mil.

Sansure Biotech's quarterly Long-Term Debt declined from Sep. 2024 (¥401 Mil) to Dec. 2024 (¥397 Mil) but then increased from Dec. 2024 (¥397 Mil) to Mar. 2025 (¥810 Mil).

Sansure Biotech's annual Long-Term Debt stayed the same from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil) but then increased from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥397 Mil).

Sansure Biotech Long-Term Debt Historical Data

The historical data trend for Sansure Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Long-Term Debt Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

396.65

Sansure Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Debt	Get a 7-Day Free Trial															390.36	395.56	400.76	396.65	810.16

Sansure Biotech (SHSE:688289) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sansure Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Executives

Tan De Yong	Core technical personnel
Wang Hai Xiao	senior management
Jie Ya Ping	Core technical personnel
Zhang Ke Ya	Core technical personnel
Yang Li	Core technical personnel
Liu Rang Jiao	Core technical personnel
Deng Zhong Ping	Senior management, core technical personnel
Zhou Jun	senior management
Zhu Jian	senior management
Wu Kang	Core technical personnel
Xiong Xiao Yan	senior management
Ji Bo Zhi	Core technical personnel
Mou Wei Min	Core technical personnel
Ren Xiao Mei	Core technical personnel
Liu Kai	senior management

Sansure Biotech Headlines

No Headlines